Marty Makary and Vinay Prasad of the FDA have proposed a streamlined framework for developing CRISPR gene-editing treatments on demand. This approach promises faster delivery of personalized medicines, potentially transforming care for families in need of urgent genetic therapies. Experts weigh in on the innovation’s impact and future possibilities in gene-editing medicine development.
Back
